Stephanie Lewis

Statistics

Publications

Citations

144

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Stephanie Lewis is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in synthetic medicinal chemistry, retrosynthetic analysis, and medicinal chemistry.

Publications per year

1998–2018

Publications

Asymmetric synthesis of (2S,3S)-3-hydroxy-2-phenylpiperidine via ring expansion

Jaemoon Lee, Thoa Hoang, Stephanie Lewis et al. · Tetrahedron Letters · 2001 · 39 citations

Natural Sciences, Chemistry, Medicinal Chemistry +9

The Impact of La Doping on Dry Reforming Ni-Based Catalysts Loaded on FSP-Alumina

Jonathan Horlyck, Stephanie Lewis, Rose Amal et al. · Topics in Catalysis · 2018 · 39 citations

Natural Sciences, Materials Engineering, Materials Science +13

Preparation of a clinically investigated ras farnesyl transferase inhibitor

Peter E. Maligres, Marjorie S. Waters, Steven A. Weissman et al. · Journal of Heterocyclic Chemistry · 2003 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +7

Efficient synthesis of N-arylpiperazinones via a selective intramolecular Mitsunobu cyclodehydration

Steven A. Weissman, Stephanie Lewis, David Askin et al. · Tetrahedron Letters · 1998 · 24 citations

Pharmacy, Chemistry, Medicinal Chemistry +5

Investigation of an optimal cell lysis method for the study of the zinc metalloproteome of Histoplasma capsulatum

Anna M. Donnell, Stephanie Lewis, Sami Abraham et al. · Analytical and Bioanalytical Chemistry · 2017 · 13 citations

Life Sciences, Biochemistry, Cell Biology +6

1–5 of 5